Fingerprint
Dive into the research topics of 'Minimal cross-intolerance with nilotinib in patients with chronic myeloid leukemia in chronic or accelerated phase who are intolerant to imatinib'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically